Form 4: Tevogen Bio Holdings Officer Sells Shares to Cover Tax Obligations

Neal Flomenberg, Chief Scientific Officer of Tevogen Bio Holdings, sold shares of common stock to satisfy tax obligations related to vesting of restricted stock units.

Summary

• Neal Flomenberg, the Chief Scientific Officer of Tevogen Bio Holdings Inc., reported the sale of common stock in three separate transactions.
• The sales occurred on March 7, 2025, March 10, 2025, and March 11, 2025.
• A total of 211,909 shares were sold to cover tax obligations related to the vesting and settlement of restricted stock units.
• The weighted average sale prices were $1.14, $1.09, and $1.05 per share on the respective dates.
• Following these transactions, Flomenberg still beneficially owns 3,828,576 shares of Tevogen Bio Holdings Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The stock sales are explained as covering tax obligations, which is a common practice. However, insider selling can sometimes create uncertainty.

Positives

• The sales were explicitly stated to be for covering tax obligations related to vested restricted stock units, suggesting no change in the officer's long-term outlook on the company.

Risks

• While the sales are attributed to tax obligations, any significant insider selling can sometimes be perceived negatively by the market.

Industry Context

Insider sales are a common occurrence, especially when related to tax obligations from vesting equity. It's important to consider the context of these sales in relation to overall company performance and insider sentiment.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, although the stated reason mitigates this concern.

Key Dates